Phase I Trial of Intratumoral Administration of Vesicula

Project: Research project

Project Details

Description

Phase I Trial of Intratumoral Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and human interferon beta (VSV-IFN-NIS), in Patients with Refractory Solid Tumors, VYRVSV2-101
StatusActive
Effective start/end date1/1/171/1/21

Funding

  • VYRIAD

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.